Related content

Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis

By Palacios Santiago  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1553-1563

Informa Healthcare

Access to resources Recommend Favorite

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

By Villiers T.   Chines A.   Palacios S.   Lips P.   Sawicki A.   Levine A.   Codreanu C.   Kelepouris N.   Brown J.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 567-576

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis

By Iwamoto Jun   Takeda Tsuyoshi   Sato Yoshihiro  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 919-928

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis

By Devogelaer J.   Brown J.   Burckhardt P.   Meunier P.   Goemaere S.   Lippuner K.   Body J.   Samsioe G.   Felsenberg D.   Fashola T.   Sanna L.   Ortmann C.   Trechsel U.   Krasnow J.   Eriksen E.   Garnero P.  

Osteoporosis International, Vol. 18, Iss. 9, 2007-09 ,pp. : 1211-1218

Springer Publishing Company

Access to resources Recommend Favorite

Safety Considerations of Adjuvant Therapy in Early Breast Cancer in Postmenopausal Women

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 1-9

Karger

Access to resources Recommend Favorite